Download PDF
Dtsch Med Wochenschr 2009; 134(25/26): 1312-1315
DOI: 10.1055/s-0029-1225281
Klinischer Fortschritt | Commentary

© Georg Thieme Verlag KG Stuttgart · New York

Hypertensiologie 2009

Hypertensiology 2009M. Middeke1
  • 1Hypertoniezentrum München
Further Information

Publication History

Publication Date:
10 June 2009 (online)

Also available at
    Permissions and Reprints

Was ist neu?

  • Neues zur Blutdruckmessung und Messgeräten.

  • „Pay for performance”: Was wir von England lernen können.

  • WASH: World Action on Salt and Health

  • ONTARGET-Studie: Kombination ACE-Hemmer + AT1-Blocker.

  • „Blutdruck-Impfung”: Impfung gegen Angiotensin II.

  • Schwer einstellbare Hypertonie: Baroreflex-Stimulation und Sympathikolyse der Nieren.

Literatur

  • 1 Ashworth M, Medina J, Morgan M. Effect of social deprivation on blood pressure monitoring and control in England: a survey of data from the quality and outcomes framework.  BMJ. 2008;  337 a2030
    Google Scholar
  • 2 Cook N R, Obarzanek E, Cutler J A. et al . Joint Effects of Sodium and Potassium Intake on Subsequent Cardiovascular Disease. The Trials of Hypertension Prevention Floow-up Study.  Arch Intern Med. 2009;  169 32-40
    Google Scholar
  • 3 Eder M JC, Holzgreve H, Liebl M E, Bogner J R. Der Einfluss von Bekleidung auf die sphygmomanometrische und oszillometrische Blutdruckmessung bei Hypertonikern.  Dtsch Med Wochenschr. 2008;  133 1288-1292
    Google Scholar
  • 4 Klaus D, Middeke M, Hoyer J. Beschränkung der Kochsalzaufnahme für die Gesamtbevölkerung? Aufruf zur Gründung einer Task Force „Weniger Salz für alle”.  Dtsch Med Wochenschr. 2008;  133 1317-1319
    Google Scholar
  • 5 Krum H, Schlaich M, Whitbourn R. et al . Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.  Lancet. 2009;  373 1275-1281
    Google Scholar
  • 6 Lane D, Beevers M, Barnes N. et al . Inter-arm differences in blood pressure: when are they clinically significant?.  J Hypertens. 2002;  20 1089-1095
    Google Scholar
  • 7 Lüders S, Schrader J, Zidek W, Berger J, Böhm M, Middeke M. et al . Prevention of Hypertension with the ACE-inhibitor Ramipril in patients with high-normal blood pressure (PHARAO) – a prospective, randomised, controlled prevention trial of the German Hypertension League.  J Hypertens. 2008;  26 1487-1496
    Google Scholar
  • 8 Madsen L B, Kirkegaard P, Pedersen E B. Health-related quality of life (SF-36) during telemonitoring of home blood pressure in hypertensive patients: A randomized, controlled study.  Blood Press. 2008;  19 1-6
    Google Scholar
  • 9 Mann J FE, Schmieder R E, McQueen M. et al . Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.  Lancet. 2008;  372 547-553
    Google Scholar
  • 10 Middeke M. Arterielle Hypertonie – Arzneimittel-Dosierung am Anfang und Ende einer Therapie.  Ther Umsch. 2008;  65 577-584
    Google Scholar
  • 11 Middeke M, Schulz E. Telemetrische Blutdruck- und Gewichtskontrolle in der Schwangerschaft. In: Goss, Middeke, Mengden, Smetak, Hrsg Praktische Telemedizin in Kardiologie und Hypertensiologie. Stuttgart, New York; Georg Thieme Verlag 2009: 161-168
    Google Scholar
  • 12 Scheffers I, Kroon A A, Tordoir J H, de Leeuw P W. Rheos Baroreflex Hypertension Therapy System to treat resistant hypertension.  Expert Rev Med Devices. 2008;  5 33-39
    Google Scholar
  • 13 Scheffers I, Schmidli J, Kroon A A. et al . Sustained blood pressure reduction by baroreflex hypertension therapy with a chronically implanted system: 2-year data from the Rheos Debut-HT study in patients with resistant hypertension.  J Hypertens. 2008;  26 (Suppl 1) S19
    Google Scholar
  • 14 The ONTARGET/TRANSCEND Investigators . Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients.  Am Heart J. 2004;  148 52-61
    Google Scholar
  • 15 The ONTARGET Investigators . Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events.  N Engl J Med. 2008;  358 1547-1559
    Google Scholar
  • 16 Tissot A C, Maurer P, Nussberger J. et al . Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study.  Lancet. 2008;  371 821-827
    Google Scholar
  • 17 Wirth A, Benyó Z, Lukasova M. et al . G12-G13-LARG-mediated signaling in vascular smooth muscle is required for salt-induced hypertension.  Nat Med. 2008;  14 64-68
    Google Scholar

Prof. Dr. med. Martin Middeke

Hypertoniezentrum München

Dienerstr. 12

80331 München

URL: http://www.hypertoniezentrum.de

      >